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Mechanotransduction
Dermal skinThe human dermal skin is permanently exposed tomechanical stress, for instance during facial expression,which
might causewrinkleswith age. Cyclicmechanical stretching of cells results in cellular and cytoskeleton alignment
perpendicular to the stretch direction regulating cellular response.With gene expression proﬁling itwas aimed to
identify the differentially expressed genes associated with the regulation of the cytoskeleton to investigate the
stretch-induced cell alignment mechanism. Here, the transcription activity of the genome in response to cyclic
mechanical stress was measured using DNA microarray technology with Agilent SurePrint G3 Human GE 8x60k
Microarrays, based on the overall measurement of the mRNA. Gene expression was measured at the beginning
of the alignment process showing ﬁrst reoriented cells after 5 h stretching and at the end after 24 h, where nearly
all cells are aligned. Gene expression data of control vs. stretched primary human dermal ﬁbroblasts after 5 h and
24 h demonstrated the regulation of differentially expressed genes associated with metabolism, differentiation
andmorphology andwere deposited at http://www.ncbi.nlm.nih.gov/geo with the accession number GSE58389.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Experimental design
Cell alignment is one of themain cellular responses to cyclicmechan-
ical uniaxial stretch [1] and might be associated with mechanically
inducedwrinkle formation in the skin [2]. The identiﬁcation of themech-
anism leading to alignmentmay allow analysis andmodulation of its role
in the formation of mechanically induced wrinkles. To identify changes
in gene expression associated with mechanical stretch-induced cell
alignment, awhole genomemicroarray studywas performedonprimary
human dermal ﬁbroblasts (PHDF) subjected to cyclic uniaxial stretching
using a Flexer®Cell Tension Plus System. Gene expressionwasmeasured
at the beginning of the alignment process showing ﬁrst reoriented cells
after 5 h stretching and at the end after 24 h, when nearly all cells are
aligned perpendicular to the stretch-direction (Fig. 1). In total, PHDF
from ten donors were cultured on BioFlex culture plates and stretched
for 5 h and 24 h or left untreated as controls to account for changes oc-
curring during cell culture. This resulted in 4 samples for each of the sub-
jects (control/treated and 5 h/24 h), i.e. 40 samples in total (Table 1).
Materials and methods
Cell culture
Dermal ﬁbroblasts were isolated from skin biopsies obtained from
plastic surgery. The biopsieswere cut in stripes and incubated in dispasethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. PHDF were cultured on BioFlex culture plates for 24 h and then stretched with the
FX-4000T™ Tension Plus™ System. Cell morphology of PHDF in response to 24 h cyclic
mechanical stretching was observed with transmitted light microscopy. Micrographs of
static cells show randomized orientated PHDF. In contrary, stretched cells were oriented
perpendicular to stretch direction.
336 M. Reichenbach et al. / Genomics Data 2 (2014) 335–339II for 3 h at 37 °C. Afterwards the dermiswas separated from the epider-
mis, cut into smaller pieces and digested in collagenase I o/n at 37 °C.
The suspension was ﬁltered and the primary human dermal ﬁbroblasts
in the ﬁltrate were seeded in cell culture ﬂasks. For long term stor-
age the PHDF were cultured until passage one in cell culture ﬂasks,Table 1
Experimental design of microarray-based gene expression proﬁling. PHDF from ten sub-
jects were cultured on BioFlex culture plates and stretched for 5 h and24 h or left untreat-
ed. RNA was isolated and used for gene expression proﬁling. Each subject provided the 4
samples with the control/treatment combinations (control; stretched).
Subject
ID
Primary human dermal ﬁbroblasts isolated from 10 subjects
Control Stretched
Sample name Array ID Sample name Array ID
5 h 392 Reu_1 co_5h_392 Reu_21 tr_5h_392
5 h 420 Reu_3 co_5h_420 Reu_23 tr_5h_420
5 h 464 Reu_5 co_5h_464 Reu_25 tr_5h_464
5 h 425 Reu_7 co_5h_425 Reu_27 tr_5h_425
5 h 432 Reu_9 co_5h_432 Reu_29 tr_5h_432
5 h 416 Reu_11 co_5h_416 Reu_31 tr_5h_416
5 h 465 Reu_13 co_5h_465 Reu_33 tr_5h_465
5 h 446 Reu_15 co_5h_446 Reu_35 tr_5h_446
5 h 387 Reu_17 co_5h_387 Reu_37 tr_5h_387
5 h 445 Reu_19 co_5h_445 Reu_39 tr_5h_445
24 h 392 Reu_2 co_24h_392 Reu_22 tr_24h_392
24 h 420 Reu_4 co_24h_420 Reu_24 tr_24h_420
24 h 464 Reu_6 co_24h_464 Reu_26 tr_24h_464
24 h 425 Reu_8 co_24h_425 Reu_28 tr_24h_425
24 h 432 Reu_10 co_24h_432 Reu_30 tr_24h_432
24 h 416 Reu_12 co_24h_416 Reu_32 tr_24h_416
24 h 465 Reu_14 co_24h_465 Reu_34 tr_24h_465
24 h 446 Reu_16 co_24h_446 Reu_36 tr_24h_446
24 h 387 Reu_18 co_24h_387 Reu_38 tr_24h_387
24 h 445 Reu_20 co_24h_445 Reu_40 tr_24h_445harvested by centrifugation (5 min, 1000 g) after Trypsin/EDTA
digestion for 5 min at 37 °C and resolved in freezing medium. PHDF
were thawed with prewarmed DMEM containing 10% FCS, 2 mM
GlutaMax™-I and 0.1 mg/ml penicillin/streptomycin, plated in cell cul-
ture ﬂasks and incubated at 37 °C in an atmosphere of 5% CO2 and 90%
humidity until conﬂuence. Then cells were subcultured in BioFlex cul-
ture plates.
Cyclic mechanical stretching in vitro
Mechanical stretchingwas performed on ﬂexible siliconmembranes
using FX-4000T™ Tension Plus™ System. PHDFwere seeded on BioFlex
culture plates coated with Collagen I and cultured until subconﬂuence
of 70% and cells were serum deprived o/n. For stretching experiments
culture plates were mounted on the Baseplate™. Cyclic stretch was ap-
plied in the FX-4000T™ Tension Plus™ System with 16% elongation,
0.5 Hz in a half sinus regimen. By application of a vacuum a depression
occurs and the silicon membranes with adhering cells were stretched
over the loading posts. Cell alignment was microscopically observed at
the outer circular region of thewell. At 5 h and 24 h cells were harvested
for mRNA isolation.
RNA isolation from primary human dermal ﬁbroblasts
PHDF from 10 donors were cultured on BioFlex culture plates for
24 h and stretched for 5 h and 24 h or left untreated. To separate the in-
homogeneous stretching areas of the BioFlex culture plates the silicon
membranes were punched with a 2 cm diameter punch. Isolation of
RNAwas donewith RNeasyMini Kit according tomanufacturer product
information from the outer circular region of the well. DNA and RNA
were precipitated with 70% ethanol and bound to a silica membrane.
DNA was digested using DNAse I. RNA was eluted with 30 μl RNAse
free water and subjected to Experion automated electrophoresis for
quality control.
Microarray hybridization and data processing
The obtained RNA was transcribed into cDNA and than subjected to
microarray hybridization. 100 ng of each total RNA sample was used for
the linear T7-based ampliﬁcation step. To produce Cy3-labeled cRNA,
the RNA samples were ampliﬁed and labeled using the Agilent Low
Input Quick Amp Labeling Kit (Agilent Technologies) following the
manufacturer's protocol. Yields of cRNA and the dye-incorporation
rate were measured with ND-1000 Spectrophotometer (NanoDrop
Technologies). The hybridization procedure was performed according
to the Agilent 60-mer oligo microarray processing protocol using the
Agilent Gene Expression Hybridization Kit (Agilent Technologies)
(Design ID 028004). Subsequently, 600 ng Cy3-labeled fragmented
cRNA in hybridization buffer was hybridized 17 h at 65 °C to Agilent
SurePrintG3HumanGE 8x60kMicroarrays usingAgilent's recommend-
ed hybridization chamber and oven. Finally, the microarrays were
washed once with the Agilent Gene Expression wash buffer 1 for
1 min at room temperature followed by a second wash with preheated
Agilent Gene Expressionwash buffer 2 (37 °C) for 1min. The last wash-
ing step was performed with acetonitrile. Fluorescence signals of the
hybridized Agilent microarrays were detected using Agilent's Microar-
ray Scanner System (G2505C, Agilent Technologies, Palo Alto, USA).
The Agilent Feature Extraction Software (FES 10.7.3.1) was used to
obtain and process the microarray image ﬁles. The preprocessing
started with the conversion of the data after using Agilent Feature Ex-
traction software in txt ﬁles suitable for all subsequent analysis steps,
which were mainly performed with the R statistical software and its
Bioconductor packages. For the preprocessing the agi4x44kpreprocess
package was used [3]. To this end an annotation package for the Agilent
Whole Genome8x60k chip has previously been created. The annotation
package for the 8x60k Agilent chip was created using Bioconductor
337M. Reichenbach et al. / Genomics Data 2 (2014) 335–339SQLForge and AnnotationDbi packages based on annotation informa-
tion provided as an Excel ﬁle by Agilent. After loading the data ﬁles
into R, all data were background-corrected. Data were then normalized
between arrays using quantile-normalization and transformed to log2-
scale, which enabled comparison of samples loaded on different arrays.
After normalization, a set of quality control stepswas performed to ﬁlter
low-quality probes. Filtering of probes was based on quality ﬂags set by
the Agilent Feature Extraction Software. Most of the probes (~42%)
were ﬁltered because of not being sufﬁciently above background.
Between sample comparisons of whole genome expression proﬁles
The processed and ﬁltered data were subjected to between sample
comparisons. To evaluate consistency for batch processing, between
sample Euclidian distances were calculated using all expression values,
scaled by row, and plotted as a false-color heat map with red indicating
high differences and blue indicating low differences between compared
samples (Fig. 2). The heat map showed lower differences between
samples from the same subject, and otherwise relatively homogenous
coloring demonstrating that gene expression of samples differed to sim-
ilar extents indicating no batch effects. Differentially expressed genesFig. 2. Between sample comparisons of gene expression changes measured with Whole genom
plates and then stretched for 5 h and 24 h or left untreated. RNA was isolated and subjected
preprocessed with statistical software R using its Bioconductor package. The false-color heat m
distances. The scaled expression value, denoted as the row Z-score, is plotted in dark red–darkwere identiﬁed using the empirical Bayes method implemented in the
limma package for the R statistical software [4,5]. Paired statistical anal-
ysis of control and treated cells at 5 h and 24 h was performed with a
Benjamini–Hochberg adjusted p-value cut-off of ≤0.05 [6–8]. Signiﬁ-
cantly expressed gene probes were ﬁltered to exclude gene probes
with a log(fold change) ≤ 0.5 to improve separation resulting in 603
differentially expressed gene probes for 5 h treatment and 177 differen-
tially expressed gene probes for 24 h treatment (for 24 h Table 2, for 5 h
Supplementary data, not assignable gene probes were excluded).
Heat maps were drawn for signiﬁcantly differentially expressed gene
probes for 5 h treatment versus control (Supplementary data) and
24 h treatment versus control comparisons (Fig. 3), using gene expres-
sion values scaled by row, with red color indicating upregulation rela-
tive to control and blue color indicating downregulation with respect
to control. The heat map of signiﬁcantly differentially expressed gene
probes for 5 h shows a less clear separation of samples according to
their treatment, control or stretched, indicating that gene expression
changes in response to 5 h stretching were less prominent. It can be as-
sumed that this is in correlation with the observed morphological phe-
notype (Fig. 1). The cell alignment process starts at 5 h and therefore the
cells are still in the reorientation process at this time point and genee 8x60k array chip hybridization. PHDF from 10 donors were cultured on BioFlex culture
to microarray-based whole genome expression proﬁling. Fluorescence intensities were
ap was drawn in R representing clustering of samples by the means of between sample
blue color code.
Table 2
Table of signiﬁcant differentially expressed genes at 24 h with scaled log(fold changes)
and p-values. Paired statistical analysis of control and treated cells at 24 h was performed
with a Benjamini–Hochberg adjusted p-value cut-off of ≤0.05. Signiﬁcantly expressed
gene probes were ﬁltered to exclude gene probes with a log(fold change) ≤ 0.5 to im-
prove separation.
24 h treatment (115 gene probes)
Log(fold
changes)
p-Value Description
0.5398 0.000671083 MIR143 host gene (non-protein coding)
0.5328 1.29E−05 Uncharacterized LOC100506860
−0.7350 6.04E−06 Uncharacterized LOC100506377
0.5595 1.11E−06 Long intergenic non-protein coding RNA 467
0.5431 3.37E−09 Uncharacterized LOC440993
0.5298 1.15E−07 Uncharacterized LOC100499194
0.6250 0.000297072 Uncharacterized LOC100505687
0.9110 2.44E−05 Kin of IRRE like 3 (Drosophila)
−0.7072 3.16E−07 Niemann–Pick disease, type C1
−0.7884 2.04E−07 Methylsterol monooxygenase 1
0.5714 6.93E−06 Cysteine-rich protein 2
0.5357 2.96E−06 Malic enzyme 3, NADP(+)-dependent,
mitochondrial
0.5403 1.90E−05 Regulator of G-protein signaling 11
−0.6491 5.66E−09 Hydroxysteroid (17-beta) dehydrogenase 7
0.5137 0.000527329 Kruppel-like factor 2 (lung)
−0.5687 1.85E−05 Tumor necrosis factor receptor superfamily,
member 14
−0.6834 3.44E−09 Syntaxin 3
−0.5257 1.85E−08 Family with sequence similarity 134, member A
0.5115 0.000514841 Slit homolog 2 (Drosophila)
−0.7784 3.27E−08 Glucosamine-6-phosphate deaminase 1
−0.5701 4.65E−07 Squalene epoxidase
−0.9861 0.000815157 Ferritin, heavy polypeptide-like 17
0.6104 6.10E−05 Synaptogyrin 4
−0.5113 3.03E−07 5 ′–3′ exoribonuclease 2
−0.5325 9.73E−10 Mannose-6-phosphate receptor
(cation dependent)
0.7487 1.92E−11 AHNAK nucleoprotein
0.7842 7.31E−05 Early growth response 1
0.5585 0.000882563 Tumor necrosis factor receptor superfamily,
member 6b, decoy
0.6287 9.97E−11 Plectin
0.5429 1.26E−07 MAD2 mitotic arrest deﬁcient-like 2 (yeast)
0.6556 2.76E−05 Chromosome 10 open reading frame 54
0.5536 0.000577494 Cell division cycle associated 7
0.5976 2.14E−05 Creatine kinase, brain
−0.5909 3.60E−05 Chromosome 14 open reading frame 1
0.5561 0.000729642 Rhomboid, veinlet-like 1 (Drosophila)
0.5233 0.000842352 Late corniﬁed envelope 1C
−0.5510 6.57E−06 3-Hydroxy-3-methylglutaryl-CoA reductase
−0.5259 1.02E-07 Basic helix–loop–helix domain containing,
class B, 9
−0.6332 8.54E-07 ATPase, H + transporting, lysosomal 56/58 kDa,
V1 subunit B2
−0.5538 4.46E-05 StAR-related lipid transfer (START) domain
containing 4
−0.6156 1.36E-07 Transmembrane protein 217
−0.5978 4.37E-05 Uncharacterized LOC197187
0.5690 0.000120951 Chromosome 14 open reading frame 80
0.5223 4.57E-05 Interleukin 17 receptor E
0.5694 0.000210521 Tubulin, alpha 3d
−0.5380 4.86E-05 Sec23 homolog B (S. cerevisiae)
0.5433 1.87E-05 MYCN opposite strand/antisense RNA
(non-protein coding)
−0.5530 4.25E-06 Malic enzyme 1, NADP(+)-dependent, cytosolic
0.5807 1.85E-05 Thioredoxin interacting protein
−0.5730 1.20E-05 Multiple coagulation factor deﬁciency 2
−0.6702 7.29E-08 Isopentenyl-diphosphate delta isomerase 1
0.6304 0.000232544 Ubiquitin-like with PHD and ring ﬁnger domains 1
−0.5725 1.55E-08 Ankyrin repeat domain 37
−0.5130 3.22E-07 Sorting nexin 3
0.6085 0.000458856 Fibrosin-like 1
−0.6386 6.17E-05 RAB9B, member RAS oncogene family
pseudogene 1
−0.5078 1.77E-05 dCMP deaminase
0.7674 0.000490824 Ribonucleoprotein, PTB-binding 1
−0.6215 4.02E-08 Sialidase 1 (lysosomal sialidase)
−0.6531 7.17E-06 Solute carrier family 43, member 3
Table 2 (continued)
24 h treatment (115 gene probes)
Log(fold
changes)
p-Value Description
0.5878 0.000128578 Chromosome 19 open reading frame 55
−0.5231 0.000172375 3-Hydroxy-3-methylglutaryl-CoA synthase
1 (soluble)
0.5502 0.000793717 Chromosome 1 open reading frame 229
−0.5190 0.000100862 Junctional adhesion molecule 3
0.6320 0.000533996 Histone cluster 1, H3i
−0.6842 0.000136983 Proprotein convertase subtilisin/kexin type 9
−0.5162 8.24E−05 NECAP endocytosis associated 1
−0.7197 3.99E−06 Stearoyl-CoA desaturase (delta-9-desaturase)
−0.5764 2.22E−07 Wilms tumor 1 associated protein
0.5780 0.000785569 Histone cluster 1, H2am
0.5660 1.36E−06 Long intergenic non-protein coding RNA 577
0.5647 0.000804159 Secretoglobin, family 3A, member 1
0.5104 1.32E−05 PDZ and LIM domain 7 (enigma)
−0.5876 8.43E−05 Insulin induced gene 1
0.5709 0.000973297 LIM homeobox 3
0.5330 0.000551954 v-Raf murine sarcoma 3611 viral oncogene
homolog 2, pseudogene
−0.5549 2.69E−07 Hydroxysteroid (17-beta) dehydrogenase 7
−0.5286 1.51E−09 NAD(P) dependent steroid dehydrogenase-like
−0.5962 7.70E−05 Paraneoplastic Ma antigen 1
−0.6144 0.000269973 Potassium voltage-gated channel, Isk-related
family, member 4
−0.5522 6.60E−10 UBX domain protein 8
−0.6874 0.000809869 Small nucleolar RNA, C/D box 3B-1
−0.5275 1.04E−07 Patched domain containing 3 pseudogene
0.7635 0.001070526 Histone cluster 2, H3a
0.5250 0.001093476 NCK adaptor protein 2
0.5829 0.000126935 Uncharacterized protein FLJ25694
0.5291 0.001058371 Homeobox A10
0.5255 2.84E−05 Collagen, type VIII, alpha 2
0.5281 0.000314357 Uncharacterized LOC643549
0.5306 0.000422623 Calcyon neuron-speciﬁc vesicular protein
0.5472 1.86E−05 Hairy and enhancer of split 6 (Drosophila)
−0.5958 0.000268984 Fas (TNF receptor superfamily, member 6)
−0.5157 1.91E−07 Heat shock 105 kDa/110 kDa protein 1
0.5736 0.00096652 Keratin 7
0.5345 1.61E−10 Chromosome 1 open reading frame 86
−0.6078 1.97E−07 Activin A receptor, type I
0.5641 0.000259433 High mobility group protein HMG-I/HMG-Y-like
−0.5045 7.21E−12 Putative homeodomain transcription factor 1
0.5329 5.05E−05 Uncharacterized LOC388152
0.5787 3.07E−05 ADAMTS-like 4
0.6463 6.78E−05 Exocyst complex component 7
0.5300 2.30E−07 Exocyst complex component 7
0.5380 0.000583772 Transmembrane protein 8C
0.5741 5.36E−05 Protein kinase, membrane associated
tyrosine/threonine 1
0.5195 0.000353071 Golgin A6 family-like 1 pseudogene
−1.0093 0.000147492 Ubiquitin speciﬁc peptidase 6 (Tre-2 oncogene)
0.5359 0.000519288 NLR family, CARD domain containing 3
0.6446 0.000549649 CD72 molecule
0.5893 2.66E−05 B1 for mucin
0.6576 1.74E−05 Small nucleolar RNA, H/ACA box 71A
−0.5154 1.08E−08 Cysteine and histidine-rich domain (CHORD)
containing 1
0.5014 1.23E−05 Uncharacterized LOC100507637
−0.6767 3.14E−06 Chloride intracellular channel 2
0.5141 0.001075593 Polycystic kidney disease 1 (autosomal dominant)
0.5094 0.000108073 Protection of telomeres 1 homolog (S. pombe)
338 M. Reichenbach et al. / Genomics Data 2 (2014) 335–339expression changes are unassertive. Heat map of differentially
expressed gene probes for 24 h demonstrates a clear separation of sam-
ples according to their treatment indicating that after 24 h stretching
gene expression was explicitly changed at that time point, when cell
alignment process was completed.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2014.09.010.
Fig. 3. The scaled gene expression for control versus stretched samples at 24 h of each probe is shown as the row Z-score; it is plotted in a red–blue color scale with red indicating high
expression and blue indicating low expression. Signiﬁcantly differentially expressed gene probes were ﬁltered to exclude gene probes with a log(fold change)≤ 0.5. Heat map of differ-
entially expressed gene probes for 24 h demonstrates a clear separation of samples according to their treatment.
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